期刊文献+

低钙透析对老年高钙血症血液透析患者的影响

The Effect of Low Calcium Dialysate in Elderly Hemodialysis Patients With Hypercalcemia
下载PDF
导出
摘要 目的探讨低钙透析在伴高钙血症的老年维持性血液透析患者中的应用。方法将48例伴高钙血症的老年维持性血液透析患者给予1.25 mmol/L钙浓度透析液治疗3个月,比较更改透析液治疗前及应用后1、3个月时血钙、血磷、钙磷乘积、全段甲状旁腺激素(iPTH)水平。结果低钙透析液治疗1个月后患者血钙、血磷、钙磷乘积明显降低,3个月后下降更明显;iPTH水平在治疗1个月后无变化,3个月后明显上升,差异有统计学意义(P<0.05)。结论高钙、高磷、低iPTH血症老年患者采用低钙透析液治疗可有效地降低血钙、血磷、钙磷乘积,提升iPTH水平。 Objective To investigate low calcium dialysate in maintenance hemodialysis senile patients of hypercalcemia. Methods 48 maintenance hemodialysis senile patients of hypercalcemia who had used low calcium dialysate (calcium concentration 1.25 mmol/L) for a period of 3 months. The serum calcium, phosphorus, calcium-phos- phorus product and intact parathyroid hormone (iPTH) levels before and 1, 3 months after the change of dialysate were compared. Results There was significant diference between low-calcium dialysate was used before and after 1 months in serum calcium, serum phosphorus, calcium-phosphorus product. After 3 months, the decline was more pronounced. The level of serum iPTH had no change after 1 months of treatment, but after 3 months was signifcantly increased, the difference was statistically significant (P 〈 0.05). Conclusion The senile patients of hypercalcemia with low calcium dialysate dialysis can effectively reduce serum calcium, serum phosphorus, calcium-phosphorus product , and improve iPTH levels.
出处 《中国卫生标准管理》 2017年第18期52-54,共3页 China Health Standard Management
关键词 低钙透析 高磷血症 高钙血症 动力缺失性骨病 low calcium dialysate hyperphosphatemia hypercalcemia adynamic bone diseas
  • 相关文献

参考文献4

二级参考文献49

  • 1卢艳慧,陆菊明,王淑玉,李春霖,刘力生,郑润平,田慧,王先令,杨丽娟,张育青,潘长玉.国际糖尿病联盟代谢综合征诊断标准中的腰围切点分析[J].中华老年多器官疾病杂志,2007,6(2):119-122. 被引量:10
  • 2李莹,纵晓英,张俊,高燕燕,刘群,黄玉萍.终末期肾病微炎症状态及相关因素分析[J].实用全科医学,2007,5(9):774-775. 被引量:9
  • 3Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guide- line for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease- Mineral and Bone Disorder (CKD-MBD) [J]. Kidney Int, 2009, 76 (Suppl 113): S1-S130.
  • 4Noordzij M, Korevaar JC, Boeschoten EW, et al. Neth- erlands Cooperative Study on the Adequacy of Dialy- sis (NECOSAD) Study Group. The Kidney Disease Out- comes Quality Initiative (K/DOQI) Guidelines for Bone Metabolism and Disease in CKD: association in dialysis patients[J]. Am J Kidney Dis, 2005, 46: 925-932.
  • 5W.G Goodman. Medical management of secondary hyper- parathyroidism in chronic renal failure[J]. Nephrol Dial Transplant, 2003,18(suppl 3):2-8.
  • 6Dialysis Outcomes and Practice Patterns Study. 2010DOPPS annual report[EB /OL]. http / /www. dopps, org /annualreport /index. html.
  • 7Teresa Adragao, Aria pires, Carlos Luca. s, et al. h simple vascular calcification score predicts car- diovaseular risk in hemodialysis patients[J]. Nephrol Dial Transplant, 2004,19:1480-1488.
  • 8Moallem E, Kilav R, Silver J, et al. RNA-Protein bind- ing and post-transcriptional regulation of parathy- roid hormone gene expression by calcium and phos- phate[J]. J Biol Chem, 1998, 273:5253- 5259.
  • 9Rodri- guez-Garcia M, Gomez-Alonso C, Naves-Diaz M, et al. Vascular calcifications, vertebral fractures and mortality in haemodialysis patients[J]. Nephrol Di- al Transplant, 2009, 24: 239-246.
  • 10Sarnak MJ. Cardiovascular complications in chronic kidney disease[J]. Am J Kidney Dis, 2003,41(5 Sup- ply): 11-17.

共引文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部